Description
The
expensive nature of doctor-recommended tests have led to high sales of
self-diagnostic testing kits. Self-diagnostic kits are easily available in
pharmacies and online. Self-monitoring blood glucose (SMBG) devices can be used
by pediatrics and geriatrics to check their blood glucose levels. They can
display predictive warnings regarding hypoglycemia and hyperglycemia
Request
Free Sample Copy - https://www.radiantinsights.com/research/global-self-monitoring-blood-glucose-smbg-devices-sales-market-report-2017/request-sample
According
to the World Health Organization (WHO), incidence of diabetes had risen to 422
million in 2014. If left untreated, it can lead to stroke, kidney failure, and
heart attacks. Various governments have made it mandatory to include diabetic
testing in health reimbursement schemes. These schemes are expected to lead to
higher purchase of SMBGs and invoke a new revolution in diabetes management.
Integration to Mobile Applications
Three
major types of SMBG devices are blood glucose lancets, blood glucose test
strips, and blood glucose meters. Blood glucose meters can gauge high glucose
levels instantly. They are integral to the geriatric populace or consumers
unable to make hospital visits. Companies have devised a non-invasive method to
detect glucose levels without causing patients any pain or discomfort.
Glucobeam, a non-invasive device developed by RSP Systems, can detect glucose
levels immediately. It can conduct nearly 4-8 tests in a day. In addition, the
integration of SMBG meters with smartphone applications lets users check
hyperglycemia levels against past tests.
Roche
Diagnostics AG, a division of F. Hoffmann-La Roche AG, introduced two blood
glucose meters, namely the Accu-Chek Guide and Accu-Chek Instant. Both these
devices will be able to connect to Medtronic insulin pumps as a result of an
agreement between Roche and Medtronic. This development will benefit consumers
of both brands by providing blood sugar level data on a common platform. Both
devices can share their readings with the help of a mobile application.
Market Overview
The
global self-monitoring blood glucose devices market is projected to attain high
revenue by 2022, according to a report on Radiant Insights, Inc. High prevalence
of diabetes is expected to drive market growth over the forecast period
(2017-2022). Current trend of self management of lifestyle diseases is
projected to influence market demand during the forecast period. Increase in
government healthcare expenditure can drive market sales. On the other hand,
lack of consumer awareness regarding these devices and unclear government
production guidelines may impede market growth
View
Full Report at- https://www.radiantinsights.com/research/global-self-monitoring-blood-glucose-smbg-devices-sales-market-report-2017
Prominent
market players include F. Hoffmann-La Roche AG, Bionime Corporation, Abbott
Laboratories, and Medtronic Public Limited
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the
basis of extensive and in-depth quantitative information, supported by
extensive analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
No comments:
Post a Comment